APA

Madsen-Duggan C. B., Debenham J. S., Walsh T. F., Toupence R. B., Huang S. X., Wang J., Tong X., Lao J., Fong T. M., Schaeffer M., Xiao J. C., Huang C. R. C., Shen C., Stribling D. S., Shearman L. P., Strack A. M., MacIntyre D. E., Van der Ploeg L. H. T. & Goulet M. T. (20070725). Lead optimization of 5,6-diarylpyridines as CB1 receptor inverse agonists. : Bioorganic & medicinal chemistry letters.

Chicago

Madsen-Duggan Christina B, Debenham John S, Walsh Thomas F, Toupence Richard B, Huang Song X, Wang Junying, Tong Xinchun, Lao Julie, Fong Tung M, Schaeffer Marie-Therese, Xiao Jing Chen, Huang Cathy R-R C, Shen Chun-Pyn, Stribling D Sloan, Shearman Lauren P, Strack Alison M, MacIntyre D Euan, Van der Ploeg Lex H T and Goulet Mark T. 20070725. Lead optimization of 5,6-diarylpyridines as CB1 receptor inverse agonists. : Bioorganic & medicinal chemistry letters.

Harvard

Madsen-Duggan C. B., Debenham J. S., Walsh T. F., Toupence R. B., Huang S. X., Wang J., Tong X., Lao J., Fong T. M., Schaeffer M., Xiao J. C., Huang C. R. C., Shen C., Stribling D. S., Shearman L. P., Strack A. M., MacIntyre D. E., Van der Ploeg L. H. T. and Goulet M. T. (20070725). Lead optimization of 5,6-diarylpyridines as CB1 receptor inverse agonists. : Bioorganic & medicinal chemistry letters.

MLA

Madsen-Duggan Christina B, Debenham John S, Walsh Thomas F, Toupence Richard B, Huang Song X, Wang Junying, Tong Xinchun, Lao Julie, Fong Tung M, Schaeffer Marie-Therese, Xiao Jing Chen, Huang Cathy R-R C, Shen Chun-Pyn, Stribling D Sloan, Shearman Lauren P, Strack Alison M, MacIntyre D Euan, Van der Ploeg Lex H T and Goulet Mark T. Lead optimization of 5,6-diarylpyridines as CB1 receptor inverse agonists. : Bioorganic & medicinal chemistry letters. 20070725.